The XBB.1.5 omicron subvariant that has been dominant in the Northeast for several weeks is now officially dominant across the U.S., according to an update from the Centers for Disease Read more
Tag: BioNTech SE ADR
China takes first steps to punish countries that imposed testing mandates for Chinese travelers
China on Tuesday suspended visas for South Koreans to enter the country for tourism or business in apparent retaliation for South Korea’s COVID-19 testing requirements for Chinese travelers, the Associated Press Read more
Federal spending bill’s pandemic provisions: more public health data, no investigation into COVID’s origin
COVID-19 cases are once again rising in the U.S., but how prepared are we for the next pandemic? That’s a question worth asking. The $1.7 trillion omnibus spending bill presented Read more
Omicron subvariants are now dominant in the U.S. as COVID cases tick up and New York City becomes a hot spot
Omicron subvariants continued to account for more new cases of COVID-19 in the U.S. in the latest week than did BA.5, according to the latest data from the Centers for Read more
IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly
The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus pandemic as the country’s zero-COVID Read more
China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says Fauci
Widespread protests across China over the government’s zero-COVID policy dominated pandemic headlines Monday, with Anthony Fauci, President Joe Biden’s chief medical adviser, weighing in with the view that the strategy does Read more
Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
As we head into the third winter of the pandemic, only about 13% of American adults — less than 11% of Americans overall — have received the bivalent COVID-19 booster. Read more
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech said Friday. Read more
WHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variants
The head of the World Health Organization said a close to 90% decline in COVID deaths globally compared to nine months ago is “cause for optimism,” but urged leaders to Read more
WHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variants
The head of the World Health Organization said a close to 90% decline in COVID deaths globally compared to nine months ago is “cause for optimism,” but urged leaders to Read more